InterMune's Roche Deal Sends Peer Group Up

By: via Benzinga
InterMune's (NASDAQ: ITMN) agreement to be acquired by Roche (OTC: RHHBY) for $74 a share sent similar drug development companies ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.